AURO-SITAGLIPTIN

Identification of Auro-Sitagliptin

No description

Google image searchProduct monograph

Active ingredient

sitagliptin (sitagliptin hydrochloride monohydrate), 25 MG

DIN: 02529866

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: AURO PHARMA INC

Date: 05-JAN-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BH — Dipeptidyl peptidase 4 (DPP-4) inhibitors (ATC, ATC/DDD)
• A10BH01 — SITAGLIPTIN (ATC/DDD)

Reference brand drug: Januvia

Pharmaceutical standard: MFR

External Links for Auro-Sitagliptin

Search on Google

• Auro-Sitagliptin side effects
• Auro-Sitagliptin dosage
• sitagliptin side effects
• sitagliptin dosage

Auro Pharma Inc

Go to Auro Pharma website to see drug product details. Sometimes you can find auro-sitagliptin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.